top of page

RESEARCH

PUBLICATIONS

GNB1 Publications

2025

  • The possible association of two novel heterozygous GNB1 variants with obesity and metabolic disorders

Karantza M, Lee H, Kitsiou S, et al. The possible association of two novel heterozygous GNB1 variants with obesity and metabolic disorders. Hormones (Athens, Greece). 2025;24(1):283-286. doi:https://doi.org/10.1007/s42000-024-00615-1

https://pubmed.ncbi.nlm.nih.gov/39581956/

  • Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene

Street D, Teare L, Georgieva T, et al. Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene. Parkinsonism & related disorders. Published online July 2025:107822. doi:https://doi.org/10.1016/j.parkreldis.2025.107822

https://pubmed.ncbi.nlm.nih.gov/40210557/

 

2024

  • GNB1-Related Rod-Cone Dystrophy: A Case Report

Conti GM, Cancellieri F, Mathieu Quinodoz, et al. GNB1-Related Rod-Cone Dystrophy: A Case Report. Case Reports in Ophthalmology. 2024;15(1):230-237. doi:https://doi.org/10.1159/000537997

https://pubmed.ncbi.nlm.nih.gov/38500542/

  • GNB1 and obesity: Evidence for a correlation between haploinsufficiency and syndromic obesity

Lotte Kleinendorst, Abawi O, Vos N, et al. GNB1 and obesity: Evidence for a correlation between haploinsufficiency and syndromic obesity. Clinical Obesity. 2024;14(4). doi:https://doi.org/10.1111/cob.12661

https://pubmed.ncbi.nlm.nih.gov/38596856/

 

  • GNB1 Encephalopathy: Clinical Case Report and Literature Review

Matas Nasvytis, Julija Čiauškaitė, Giedrė Jurkevičienė. GNB1 Encephalopathy: Clinical Case Report and Literature Review. Medicina. 2024;60(4):589-589. doi:https://doi.org/10.3390/medicina60040589

‌https://pubmed.ncbi.nlm.nih.gov/38674235/

  • Novel GNB1 Variant and the Development of Spastic Diplegic Cerebral Palsy

Piché JV, Shevell M. Novel GNB1 Variant and the Development of Spastic Diplegic Cerebral Palsy. The Canadian journal of neurological sciences Le journal canadien des sciences neurologiques. Published online 2024:1-2. doi:https://doi.org/10.1017/cjn.2024.318

https://pubmed.ncbi.nlm.nih.gov/39473170/

 

 

2023

  • Rod-cone dystrophy in an adult with GNB1-related disorder: An expansion of the phenotype and natural history

Yang XR, Kassam F, Innes AM. Rod-cone dystrophy in an adult with GNB1-related disorder: An expansion of the phenotype and natural history. American journal of medical genetics Part C, Seminars in medical genetics. 2023;193(2):183-187. doi:https://doi.org/10.1002/ajmg.c.32045

https://pubmed.ncbi.nlm.nih.gov/37212526/

  • Comment on “Cutaneous mastocytosis in a child with a de novo GNB1 mutation

Ramírez CG, Azaña Defez JM, Clemente SP, Sanz PL, Córdoba SM. Comment on “Cutaneous mastocytosis in a child with a de novo GNB1 mutation.” Pediatric dermatology. 2023;40(6):1164-1165. doi:https://doi.org/10.1111/pde.15279

https://pubmed.ncbi.nlm.nih.gov/37970691/

  • Atypical clinical course in two patients with GNB1 variants who developed acute encephalopathy

Tsuji M, Ikeda A, Tsuyusaki Y, et al. Atypical clinical course in two patients with GNB1 variants who developed acute encephalopathy. Brain Dev. 2023;45(8):462-466. doi:10.1016/j.braindev.2023.06.005

https://pubmed.ncbi.nlm.nih.gov/37453880/ 

 

 

2022

  • Cutaneous mastocytosis in a child with a de novo GNB1 mutation

Lattanzio K, Larijani M, Treat JR. Cutaneous mastocytosis in a child with a de novo GNB1 mutation. Pediatric dermatology. 2022;39(2):328-329. doi:https://doi.org/10.1111/pde.14913

https://pubmed.ncbi.nlm.nih.gov/35119134/

  • Fever‐Induced and Early Morning Paroxysmal Dyskinesia in a Man With GNB1 Encephalopathy

Galosi S, Pollini L, Nardecchia F, Cellini E, Guerrini R, Leuzzi V. Fever‐Induced and Early Morning Paroxysmal Dyskinesia in a Man With GNB1 Encephalopathy. Movement Disorders Clinical Practice. 2022;9(S2). doi:https://doi.org/10.1002/mdc3.13525

https://pubmed.ncbi.nlm.nih.gov/36118517/

 

 

2021

  • Identification of a GNB1 gene variant in a child with autosomal dominant mental retardation 42

Ren Y, Lyu Y, Ma J, et al. Identification of a GNB1 gene variant in a child with autosomal dominant mental retardation 42. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics. 2021;38(6):565-568. doi:https://doi.org/10.3760/cma.j.cn511374-20200121-00044

https://pubmed.ncbi.nlm.nih.gov/34096027/

  • Genotype-phenotype correlation in GNB1-related neurodevelopmental disorder: Potential association of p.Leu95Pro with cleft palate.

Lansdon LA, Saunders CJ. Genotype-phenotype correlation in GNB1-related neurodevelopmental disorder: Potential association of p.Leu95Pro with cleft palate. American journal of medical genetics Part A. 2021;185(4):1341-1343. doi:https://doi.org/10.1002/ajmg.a.62080

https://pubmed.ncbi.nlm.nih.gov/33427398/

  • Case Report: A Novel GNB1 Mutation Causes Global Developmental Delay with Intellectual Disability and Behavioral Disorders

Da Silva JD, Costa MD, Almeida B, Lopes F, Maciel P, Teixeira-Castro A. Case Report: A Novel GNB1 Mutation Causes Global Developmental Delay with Intellectual Disability and Behavioral Disorders. Front Neurol. 2021;12:735549. 2021. doi:10.3389/fneur.2021.735549

https://pubmed.ncbi.nlm.nih.gov/34646230/  

 

 

2020

  • Phenotype-genotype correlations in patients with GNB1 gene variants, including the first three reported Japanese patients to exhibit spastic diplegia, dyskinetic quadriplegia, and infantile spasms

Endo W, Ikemoto S, Togashi N, et al. Phenotype-genotype correlations in patients with GNB1 gene variants, including the first three reported Japanese patients to exhibit spastic diplegia, dyskinetic quadriplegia, and infantile spasms. Brain & development. 2020;42(2):199-204. doi:https://doi.org/10.1016/j.braindev.2019.10.006

https://pubmed.ncbi.nlm.nih.gov/31735425/

  • GNB1 Encephalopathy

Revah-Politi A, Sands TT, Colombo S, Goldstein DB, Anyane-Yeboa K. GNB1 Encephalopathy. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 2020.

https://pubmed.ncbi.nlm.nih.gov/32134617/ 

 

 

2019

  • Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation

Jones HF, Morales-Briceño H, Barwick K, et al. Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation. Movement disorders : official journal of the Movement Disorder Society. 2019;34(7):1079-1080. doi:https://doi.org/10.1002/mds.27708

https://pubmed.ncbi.nlm.nih.gov/31034681/

 

 

2018

  • Refining the phenotype associated with GNB1 mutations: Clinical data on 18 newly identified patients and review of the literature

Hemati P, Revah-Politi A, Bassan H, et al. Refining the phenotype associated with GNB1 mutations: Clinical data on 18 newly identified patients and review of the literature. Am J Med Genet A. 2018;176(11):2259-2275. doi:10.1002/ajmg.a.40472

https://pubmed.ncbi.nlm.nih.gov/30194818/ 

  • Novel GNB1 de novo mutation in a patient with neurodevelopmental disorder and cutaneous mastocytosis: Clinical report and literature review

Szczałuba K, Biernacka A, Szymańska K, et al. Novel GNB1 de novo mutation in a patient with neurodevelopmental disorder and cutaneous mastocytosis: Clinical report and literature review. Eur J Med Genet. 2018;61(3):157-160. doi:10.1016/j.ejmg.2017.11.010. 

https://pubmed.ncbi.nlm.nih.gov/29174093/ 

 

 

2017

  • Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans

Lohmann K, Masuho I, Patil DN, et al. Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans. Hum Mol Genet. 2017;26(6):1078-1086. doi:10.1093/hmg/ddx018. 

https://academic.oup.com/hmg/article/26/6/1078/2901823 

 

2016

  • Novel GNB1 missense mutation in a patient with generalized dystonia, hypotonia, and intellectual disability

Steinrücke S, Lohmann K, Domingo A, et al. Novel GNB1 missense mutation in a patient with generalized dystonia, hypotonia, and intellectual disability. Neurology Genetics. 2016;2(5):e106. doi:https://doi.org/10.1212/NXG.0000000000000106

https://pubmed.ncbi.nlm.nih.gov/27668284/

  • Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures

Petrovski S, Küry S, Myers CT, et al. Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures. Am J Hum Genet. 2016;98(5):1001-1010. doi:10.1016/j.ajhg.2016.03.011. 

https://pubmed.ncbi.nlm.nih.gov/27108799/

G-protein Publications

  • Heterotrimeric G-proteins: a short history

Milligan G, Kostenis E. Heterotrimeric G-proteins: a short history. Br J Pharmacol. 2006;147 Suppl 1(Suppl 1):S46-S55. doi:10.1038/sj.bjp.0706405

https://pubmed.ncbi.nlm.nih.gov/16402120/#:~:text=The%20heterotrimeric%20guanine%20nucleotide%2Dbinding,degradation%20of%20intracellular%20second%20messengers 
 

  • Epilepsy in a mouse model of GNB1 encephalopathy arises from altered potassium (GIRK) channel signaling and is alleviated by a GIRK inhibitor

Colombo S, Reddy HP, Petri S, et al. Epilepsy in a mouse model of GNB1 encephalopathy arises from altered potassium (GIRK) channel signaling and is alleviated by a GIRK inhibitor. Front Cell Neurosci. 2023;17:1175895. Published 2023 May 18. doi:10.3389/fncel.2023.1175895.
https://pubmed.ncbi.nlm.nih.gov/37275776/ 

  • Encephalopathy-causing mutations in Gβ1 (GNB1) alter regulation of neuronal GIRK channels

Reddy HP, Yakubovich D, Keren-Raifman T, et al. Encephalopathy-causing mutations in Gβ1 (GNB1) alter regulation of neuronal GIRK channels. iScience. 2021;24(9):103018. doi:https://doi.org/10.1016/j.isci.2021.103018

https://pubmed.ncbi.nlm.nih.gov/34522861/

  • Unraveling Pathogenic Mechanisms in a Complex Neurodevelopmental Disorder

Wagnon JL. Neurons Are GIRKed in GNB1 Encephalopathy: Unraveling Pathogenic Mechanisms in a Complex Neurodevelopmental Disorder. Epilepsy Currents. 2023;23(6):381-382. doi:https://doi.org/10.1177/15357597231202859

https://pubmed.ncbi.nlm.nih.gov/38269351/

  • Neurons Are GIRKed in GNB1 Encephalopathy: Unraveling Pathogenic Mechanisms in a Complex Neurodevelopmental Disorder

Wagnon JL. Neurons Are GIRKed in GNB1 Encephalopathy: Unraveling Pathogenic Mechanisms in a Complex Neurodevelopmental Disorder. Epilepsy Currents. 2023;23(6):381-382. doi:https://doi.org/10.1177/15357597231202859

https://pubmed.ncbi.nlm.nih.gov/38269351/

 

  • Sensory regulation of absence seizures in a mouse model of Gnb1 encephalopathy

Teng S, Zhen F, McRae BR, Zhu E, Frankel WN, Peng Y. Sensory regulation of absence seizures in a mouse model of Gnb1 encephalopathy. iScience. 2022;25(11):105488. doi:https://doi.org/10.1016/j.isci.2022.105488

https://pubmed.ncbi.nlm.nih.gov/36405774/

 

  • GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling

Zhang X, Dong K, Zhang J, et al. GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling. Cancer Science. 2023;114(5):2001-2013. doi:https://doi.org/10.1111/cas.15741

https://pubmed.ncbi.nlm.nih.gov/36718954/

 

  • Integrative proteomic and lipidomic analysis of GNB1 and SCARB2 knockdown in human subcutaneous adipocytes

Kitamoto T, Kitamoto A. Integrative proteomic and lipidomic analysis of GNB1 and SCARB2 knockdown in human subcutaneous adipocytes. Loor JJ, ed. PLOS ONE. 2025;20(3):e0319163. doi:https://doi.org/10.1371/journal.pone.0319163

https://pubmed.ncbi.nlm.nih.gov/40127054/

Therapies and Drug-related

  • Hit identification for membrane protein drug discovery

Rawlins P. Hit identification for membrane protein drug discovery. Drug Target Review. 2025. 

https://www.drugtargetreview.com/article/158267/advancements-in-hit-identification-for-membrane-protein-drug-discovery/ 

 

  • The expanding roles of Gβγ subunits in G protein-coupled receptor signaling and drug action

Khan SM, Sleno R, Gora S, et al. The expanding roles of Gβγ subunits in G protein-coupled receptor signaling and drug action. Pharmacol Rev. 2013;65(2):545-577. 2013. doi:10.1124/pr.111.005603

https://pubmed.ncbi.nlm.nih.gov/23406670/ 

 

  • A case report of a novel GNB1 pathogenic variant and the response to deep brain stimulation

Rožmarić G, Hero M, Rački V, Vuletić V, Chudy D, Peterlin B. A case report of a novel GNB1 pathogenic variant and the response to deep brain stimulation. Acta neurologica Belgica. 2023;123(2):603-605. doi:https://doi.org/10.1007/s13760-022-01883-7

https://pubmed.ncbi.nlm.nih.gov/35122616/

 

  • Sensory Integration Therapies for Children With Developmental and Behavioral Disorders

American Academy of Pediatrics. Sensory Integration Therapies for Children With Developmental and Behavioral Disorders. PEDIATRICS. 2012;129(6):1186-1189. doi:https://doi.org/10.1542/peds.2012-0876

https://pubmed.ncbi.nlm.nih.gov/22641765/

  • Effectiveness of Neurodevelopmental Treatment and Sensory Integration Therapy on Gross Motor Function, Balance and Gait Parameters in Children With Spastic Diplegia

Raipure A, Kovela RK, Harjpal P, Raipure A, Sr RKK, Harjpal P. Effectiveness of Neurodevelopmental Treatment and Sensory Integration Therapy on Gross Motor Function, Balance and Gait Parameters in Children With Spastic Diplegia. Cureus. 2023;15(8). doi:https://doi.org/10.7759/cureus.43876

https://pmc.ncbi.nlm.nih.gov/articles/PMC10511346/

Thanks for submitting!

The GNB1 Advocacy Group is a 501(c)(3) public charity. Our tax identification number is 99-1719087.

© 2025 GNB1 Advocacy

bottom of page